The Who and Why of Herpes Zoster Vaccination in Patients With Inflammatory Bowel Diseases
- PMID: 30153518
- DOI: 10.1016/j.cgh.2018.08.061
The Who and Why of Herpes Zoster Vaccination in Patients With Inflammatory Bowel Diseases
Comment in
-
Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease.Clin Gastroenterol Hepatol. 2019 Jul;17(8):1648-1649. doi: 10.1016/j.cgh.2019.01.045. Epub 2019 Feb 1. Clin Gastroenterol Hepatol. 2019. PMID: 30716476 No abstract available.
Comment on
-
Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.Clin Gastroenterol Hepatol. 2018 Dec;16(12):1919-1927.e3. doi: 10.1016/j.cgh.2017.12.052. Epub 2018 Jan 5. Clin Gastroenterol Hepatol. 2018. PMID: 29309905
-
Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.Clin Gastroenterol Hepatol. 2018 Dec;16(12):1928-1936.e2. doi: 10.1016/j.cgh.2018.05.024. Epub 2018 May 29. Clin Gastroenterol Hepatol. 2018. PMID: 29857150
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
